Welcome to our dedicated page for Ainos news (Ticker: AIMD), a resource for investors and traders seeking the latest updates and insights on Ainos stock.
Ainos, Inc. reports developments tied to its transition toward AI-powered scent intelligence and industrial sensing. The company centers its commercial focus on AI Nose, an electronic olfaction platform that uses sensor arrays and proprietary artificial intelligence models, including its Smell Language Model, to convert volatile organic compound and scent signals into machine-readable Smell ID data.
Recurring news themes include AI Nose commercialization across semiconductor manufacturing, robotics, smart infrastructure, and healthcare-related environments; distribution and deployment relationships; industry classification updates; and financial results connected to the platform. Ainos also maintains a therapeutic-development program around VELDONA, a low-dose oral interferon program targeting rare, autoimmune, and infectious diseases.
Ainos (NASDAQ:AIMD / AIMDW) will participate in a fireside chat with Water Tower Research on Monday, January 26, 2026 at 11:00 a.m. ET.
The company will discuss its dual-engine SmellTech platform, partnership with Trusval Technology, progress scaling AI Nose technology toward commercial deployment, and strategic priorities for 2026. The event is listen-only and a replay will be posted under "Events" on Ainos' investor relations site.
Ainos (NASDAQ:AIMD) is advancing AI Nose from R&D toward scaled commercial deployment in 2026, supported by a dual-engine architecture separating hardware sensing and a software ScentAI layer. A three-year distribution and deployment agreement with Trusval Technology includes an initial minimum commitment of 600 AI Nose units, targeting front-end semiconductor wafer fabrication and broader manufacturing use cases. The structure aims to enable recurring, SaaS-style revenue through APIs, licensing, and subscriptions while expanded deployments feed a growing Smell ID library and machine-learning performance. Ainos relocated its U.S. headquarters to Houston, Texas in early 2026 to align with industrial and semiconductor ecosystems.
Ainos (NASDAQ:AIMD) announced a distribution and deployment agreement with Taiwan-based Trusval Technology on January 7, 2026 to expand AI Nose into semiconductor front-end manufacturing.
Under the contract, Trusval will be Ainos' authorized sales agent and deployment partner for front-end wafer fab applications, with an initial minimum purchase commitment of 600 AI Nose units to support real-world deployments and scent data accumulation in high-precision manufacturing environments.
The deal extends Ainos' SmellTech footprint upstream from back-end processes and aligns with the company's 2026 execution focus on disciplined, contract‑driven platform expansion.
Ainos (NASDAQ:AIMD) outlined a long-term platform strategy to digitize smell as a native AI data language and described a dual-engine SmellTech architecture split between hardware sensing and AI intelligence.
Ainos will own design, manufacturing, deployment, and data generation for its AI Nose sensors while wholly owned ScentAI will develop the Smell Language Model (SLM) to classify, contextualize, and scale scent data via APIs, SaaS, and model licensing. 2026 priorities target scaled deployments in advanced semiconductor manufacturing and robotics to accelerate data accumulation and SLM training.
Ainos (NASDAQ:AIMD / AIMDW) will relocate its U.S. headquarters to Houston, Texas in early 2026 and has formed a wholly owned software subsidiary, ScentAI Inc.
ScentAI will develop a smell language model (SLM) that converts scent signals into Smell ID tokens and will be co-located with Ainos' HQ to integrate AI Nose hardware data with model development. Management described the move as improving operating efficiency and enabling U.S. commercialization after recent deployments in Asia.
Ainos (NASDAQ:AIMD) reported third-quarter 2025 developments as it accelerates commercial scale-up of its AI Nose scent‑digitization platform ahead of 2026. Key operational moves include expanding industrial partnerships to six, a distribution agreement with Topco across the U.S., Taiwan, Japan and Southeast Asia, a strategic partnership with NEXCOM (Oct 14, 2025), and reclassification under GICS to Technology Hardware, Storage & Peripherals effective Oct 1, 2025. The company launched its first commercial portable AI Nose (Aug 14, 2025) and added seven patents on Sep 30, 2025, bringing the total to 123 active patents. Management cited cost discipline with S,G&A down 22% YoY and total operating expenses down 8%.
Ainos (NASDAQ:AIMD) announced a strategic partnership with NEXCOM to integrate its AI Nose scent‑based edge AI solution into NEXCOM's industrial edge computing and automation platforms. The collaboration is Ainos' sixth industrial partnership in 2025 and aims to enable real‑time environmental sensing, predictive maintenance, and improved sustainability by processing olfactory data at the edge instead of the cloud. The deal leverages NEXCOM's network of 117 partners across 50 countries and aligns with an edge AI market projected at $57–$66 billion by 2030. Ainos targets a commercial launch in 2026 for AI Nose and cites enhanced industrial channels via NEXCOM's global footprint.
Ainos (NASDAQ:AIMD) announced a strategic partnership with NEXCOM on October 14, 2025 to integrate Ainos' AI Nose hardware, SmellTech, and Smell Language Model into NEXCOM's industrial edge AI and automation platforms.
The collaboration targets real-time environmental sensing for manufacturing and industrial applications, enabling intelligent monitoring, predictive maintenance, and sustainable operations while leveraging NEXCOM's global edge computing footprint and channels.
Ainos (NASDAQ:AIMD) was reclassified under GICS from biotechnology to the technology sector effective October 1, 2025, reflecting its shift to an AI-powered digital olfaction platform, AI Nose.
Water Tower Research highlighted commercial milestones: first revenue of $110,000 from a 1H 2025 elderly care pilot, a three-year SmellTech-as-a-Service order worth $2.1 million for semiconductor manufacturing, seven Japan pilots with a robotic partner, five new industry partners, and an expanded IP portfolio now at 123 active patents and applications including seven recent patents across Europe, Germany, Taiwan, and China. Large-scale commercialization is scheduled for 2026.
Ainos (NASDAQ:AIMD) announced its reclassification under GICS to Technology Hardware, Storage & Peripherals sector (Code 45202030), effective October 1, 2025. The company, transitioning from biotechnology, is positioning itself as a technology innovator in digital olfaction with its AI Nose platform powered by smell language model (SLM).
Key achievements include a 435% year-over-year revenue growth in 1H 2025 from senior care initiatives in Japan and securing a $2.1 million multi-year SmellTech-as-a-Service subscription contract for semiconductor manufacturing. Ainos has established strategic partnerships with five industry leaders: ASE Technology Holding, Topco Scientific, Kenmec Mechanical Engineering, Solomon Technology, and ugo, Inc., to accelerate SmellTech adoption across semiconductors, robotics, and automation sectors.